![]() For other uses, please contact the original authors to seek permission. Training is required and can be obtained from the authors or from the Alzheimer’s Disease Cooperative Study.įree of charge to healthcare professionals for non-commercial clinical or research purposes. The ADAS-COG is administered by a neuropsychologist or psychologist. ADAS-COG is widely used as an outcome measure in drug and therapy treatments aimed at delaying cognitive decline in dementia. It is recommended for second-stage or in-depth assessments and/or for particular research evaluations rather than for applications in routine care settings. The ADAS-COG is used for comprehensive cognitive assessment. Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. Dementia and Geriatric Cognitive Disorders, 36(3–4), 242. Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Hsieh, S., Schubert, S., Hoon, C., Mioshi, E., & Hodges, J.The ACE-III can be used for free in clinical practice and research projects. The ACE-III is administered by healthcare professionals. It is useful for differential diagnosis between Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease dementia and related neurodegenerative conditions. The ACE-III is a comprehensive screening tool that is the recommended instrument for all dementias when shorter screens are inconclusive.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |